Development of multifunctional molecules as potential therapeutic candidates for Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis in the …

MG Savelieff, G Nam, J Kang, HJ Lee, M Lee… - Chemical …, 2018 - ACS Publications
Neurodegenerative diseases pose a substantial socioeconomic burden on society.
Unfortunately, the aging world population and lack of effective cures foreshadow a negative …

The neuroprotective role of melatonin in neurological disorders

BS Alghamdi - Journal of neuroscience research, 2018 - Wiley Online Library
Melatonin is a neurohormone secreted from the pineal gland and has a wide‐ranging
regulatory and neuroprotective role. It has been reported that melatonin level is disturbed in …

Acetylcholinesterase inhibitors in the treatment of neurodegenerative diseases and the role of acetylcholinesterase in their pathogenesis

ŁJ Walczak-Nowicka, M Herbet - International journal of molecular …, 2021 - mdpi.com
Acetylcholinesterase (AChE) plays an important role in the pathogenesis of
neurodegenerative diseases by influencing the inflammatory response, apoptosis, oxidative …

Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus

G Mushtaq, NH Greig, JA Khan… - CNS & Neurological …, 2014 - ingentaconnect.com
Both Alzheimer's disease (AD) and Type 2 diabetes mellitus (T2DM) share the presence of
systemic and neuro-inflammation, enhanced production and accumulation of β-amyloid …

Acetylcholinesterase—new roles for an old actor

H Soreq, S Seidman - Nature Reviews Neuroscience, 2001 - nature.com
The discovery of the first neurotransmitter—acetylcholine—was soon followed by the
discovery of its hydrolysing enzyme, acetylcholinesterase. The role of acetylcholinesterase …

The present and future of pharmacotherapy of Alzheimer's disease: A comprehensive review

A Anand, AA Patience, N Sharma, N Khurana - European journal of …, 2017 - Elsevier
Alzheimer's disease (AD) is a generalized term used for the loss in memory and other
intellectual abilities on levels serious enough to interfere with daily life. It accounts for 60 …

Targeting acetylcholinesterase and butyrylcholinesterase in dementia

RM Lane, SG Potkin, A Enz - International Journal of …, 2006 - academic.oup.com
Abstract The cholinesterase inhibitors (ChE-Is) attenuate the cholinergic deficit underlying
the cognitive and neuropsychiatric dysfunctions in patients with AD. Inhibition of brain …

On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis

RT Bartus - Experimental neurology, 2000 - Elsevier
Life's Journey If life is indeed a journey, then poetry must be the map that reveals all its
topographic possibilities… while science is the compass that keeps us from getting lost.—RT …

Huperzine A and its neuroprotective molecular signaling in Alzheimer's disease

MJ Friedli, NC Inestrosa - Molecules, 2021 - mdpi.com
Huperzine A (HupA), an alkaloid found in the club moss Huperzia serrata, has been used for
centuries in Chinese folk medicine to treat dementia. The effects of this alkaloid have been …

β-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies

M Bartolini, C Bertucci, V Cavrini, V Andrisano - Biochemical pharmacology, 2003 - Elsevier
The aggregation of β-amyloid (1–40)(Aβ) induced by human recombinant
acetylcholinesterase (HuAChE) was studied by means of circular dichroism (CD) and by …